GlassScriptPhysician profile
Caitlin Merrin Romeo
NPI 1720439144
$6,006.21
in general payments reported to CMS, 2019-2025
15 companies · $824 in 2025
The $824 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $134 · 2020: $78.74 · 2021: $939 · 2022: $1,346 · 2023: $1,309 · 2024: $1,376 · 2025: $824.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,682 · Food and Beverage: $1,533 · Education: $294.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,682.34 |
| Food and Beverage | $1,532.60 |
| Education | $293.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $3,770.40 | 2020-2025 | Mitraclip, Triclip, Ensite |
| Cardiovascular Systems INC. | $412.14 | 2021-2023 | Diamondback Peripheral |
| Shockwave Medical, INC | $312.00 | 2022-2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Medtronic, INC. | $286.88 | 2021-2024 | Cobalt Dr Mri Surescan, Micra |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $229.22 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $200.07 | 2019-2023 | Xarelto |
| Biosense Webster, INC. | $157.69 | 2022-2023 | Na |
| Abiomed | $139.18 | 2024 | Impella |
| Cordis US Corp. | $132.66 | 2022 | |
| Actelion Pharmaceuticals US, INC. | $126.77 | 2022 | |
| Pfizer INC. | $87.44 | 2022 | |
| Boston Scientific Corporation | $77.40 | 2021-2022 | |
| Medtronic Vascular, INC. | $35.75 | 2020 | |
| Lantheus Medical Imaging, INC. | $25.88 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $12.73 | 2023 | Farxiga |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Caitlin Merrin Romeo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.